Ameritas Investment Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$150K Sell
2025
Q2
$175K Buy
2025
Q1
$138K Hold
2024
Q4
$176K Buy
2024
Q3
$159K Buy
2024
Q2
$152K Buy
2024
Q1
$135K Hold
2023
Q4
$134K Hold
2023
Q3
$104K Buy
2023
Q2
$84.2K Buy
2023
Q1
$67.6K Hold
2022
Q4
$88.3K Hold
2022
Q3
$107K Hold
2022
Q2
$82K Buy
2022
Q1
$64K Hold
2021
Q4
$153K Buy
2021
Q3
$50K Buy
2021
Q2
$60K Buy